Warning lights
Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.
-
Figures corrected NBB
Corrected annual account filed for 2025.
Financials
Financial year 2025
PHARMALIA from Saint-Nicolas, company number BE0831479941, closed financial year 2025 with a result of € 299,863 after tax. For that financial year PHARMALIA recorded a gross margin of € 359,932 and equity of € 963,883. Compared with financial year 2024, the result moved from € 94,302 to € 299,863. Profitable, and profit is growing. The buffer is growing. A strong own buffer against the debts. The most recent annual accounts were filed with the National Bank of Belgium on September 30, 2026.
€ 963,883
▲ 45% vs 2024
Assets minus debts, by the books. What is left if everything were sold and paid today.
€ 299,863
▲ 218% vs 2024
Profit after tax over the fiscal year.
€ 3,355
▲ € 3,183 vs 2024
Cash and bank balances on the last day of the fiscal year.
Stays in the company
No dividend for 2025. Retained profit grew to € 951,483.
People and assets in 2025
€ 13,258
▼ 33% vs 2024
Book value of vehicles, furniture and equipment.
Debts at end 2025
€ 9,510
▼ 91% vs 2024
€ 6,210 is repaid this year. At this pace the long-term loan is gone in ≈ 2 years.
€ 115,949
▼ 4% vs 2024
Corporate tax and VAT still to pay. No wage debt: nothing outstanding to staff or social security.
| 2022 | 2023 | 2024 | 2025 | Change 2024 → 2025 | |
|---|---|---|---|---|---|
| Gross margin | € 160,738 | € 155,381 | € 162,122 | € 359,932 | ▲ 122% |
| Profit after taxes | € 97,587 | € 93,867 | € 94,302 | € 299,863 | ▲ 218% |
| Equity | € 475,851 | € 569,718 | € 664,020 | € 963,883 | ▲ 45% |
| Total debts | € 366,236 | € 314,296 | € 242,565 | € 196,944 | ▼ 19% |
| Cash | € 12,778 | € 0 | € 171 | € 3,355 | ▲ € 3,183 |
| Retained profit | € 463,451 | € 557,318 | € 651,620 | € 951,483 | ▲ 46% |
| Bank debt | € 215,459 | € 179,731 | € 111,653 | € 9,510 | ▼ 91% |
| Balance sheet total | € 842,087 | € 884,014 | € 906,585 | € 1,160,827 | ▲ 28% |
Key figures of PHARMALIA, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 July 2027.
What happened to PHARMALIA?
What happened at PHARMALIA in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:
- Corrected annual accounts filed for financial year 2025. filed late Source: NBB ↗
- New establishment in Saint-Nicolas. KBO
- NAJAT FASKA became a director. NBB
- Start of the company according to the CBE. KBO
In short
From € 97,587 profit in 2022 to € 299,863 profit in 2025.
Paid € 201,623 in corporate taxes since 2022.
Best year ever: 2025, with € 299,863 profit.
Management
Behind PHARMALIA is NAJAT FASKA.
Directors
According to the 2025 annual accounts
NAJAT FASKA
Director
since 2010
Establishments
Establishment units
Physical locations of this company
Rue Malaise 91
4420 Saint-Nicolas
What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.
Details
- Company number
- 0831.479.941
- VAT number
- BE 0831.479.941
- Registered office
- Rue Malaise 91, 4420 Saint-Nicolas
- Names & denominations
- PHARMALIA
- Enterprise type
- Rechtspersoon
- Legal form
- Private limited company
- Legal situation
- Normale toestand
- Start date
- 29 November 2010
- Peppol
- Active · Active since 19 Dec 2025
- Activities · NACE
Activiteiten van adviesbureaus op het gebied van bedrijfsvoering en overig managementadvies
Overige adviesbureaus op het gebied van bedrijfsbeheer; adviesbureaus op het gebied van bedrijfsvoering
Handel in eigen onroerend goed
Activiteiten van holdings
Overige fiscale dienstverlening
Holdings
Accountants en belastingconsulenten